These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22212275)

  • 1. Changes in cardiovascular risk factors and inflammatory markers of young, healthy, men after six weeks of moderate or high intensity resistance training.
    Sheikholeslami Vatani D; Ahmadi S; Ahmadi Dehrashid K; Gharibi F
    J Sports Med Phys Fitness; 2011 Dec; 51(4):695-700. PubMed ID: 22212275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in antioxidant status and cardiovascular risk factors of overweight young men after six weeks supplementation of whey protein isolate and resistance training.
    Sheikholeslami Vatani D; Ahmadi Kani Golzar F
    Appetite; 2012 Dec; 59(3):673-8. PubMed ID: 22889987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease.
    Mansfield E; McPherson R; Koski KG
    J Am Diet Assoc; 1999 Nov; 99(11):1373-9. PubMed ID: 10570674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microalbuminuria and atherosclerosis risk factors in potentially healthy men--preliminary data].
    Kade G; Wierzbicki P; Prokopiuk-Wierzbicka M; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):114-8. PubMed ID: 15603318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [C-reactive protein as a new risk factor of coronary heart disease in the population of young Polish males].
    Olszewski R; Grabysa R; Warmiński J; Makowski T; Szczechowicz R; Piechota W; Adamus J
    Pol Merkur Lekarski; 2002 Jul; 13(73):14-7. PubMed ID: 12362497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
    El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
    Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study.
    Holme I; Høstmark AT; Anderssen SA
    J Intern Med; 2007 Aug; 262(2):235-43. PubMed ID: 17645591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
    Fu ZF; Liu ML
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory cardiovascular risk markers in women with hypopituitarism.
    Sesmilo G; Miller KK; Hayden D; Klibanski A
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5774-81. PubMed ID: 11739438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory status modulates plasma lipid and inflammatory marker responses to kiwifruit consumption in hypercholesterolaemic men.
    Gammon CS; Kruger R; Conlon CA; von Hurst PR; Jones B; Stonehouse W
    Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):91-9. PubMed ID: 24099724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes.
    Kadoglou NP; Fotiadis G; Athanasiadou Z; Vitta I; Lampropoulos S; Vrabas IS
    Endocrine; 2012 Dec; 42(3):561-9. PubMed ID: 22407494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk profile in 38-year and 18-year-old men. Contribution of body fat content and regional fat distribution.
    Bonora E; Targher G; Branzi P; Zenere M; Saggiani F; Zenti MG; Travia D; Tonoli M; Muggeo M; Cigolini M
    Int J Obes Relat Metab Disord; 1996 Jan; 20(1):28-36. PubMed ID: 8788319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
    Yanni AE; Perrea DN; Yatzidis HA
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
    Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
    Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exercise program on appetite-regulating hormones, inflammatory mediators, lipid profiles, and body composition in healthy men.
    Pil-Byung C; Shin-Hwan Y; Il-Gyu K; Gwang-Suk H; Jae-Hyun Y; Han-Joon L; Sung-Eun K; Yong-Seok J
    J Sports Med Phys Fitness; 2011 Dec; 51(4):654-63. PubMed ID: 22212269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high-intensity circuit training, low-intensity circuit training and endurance training on blood pressure and lipoproteins in middle-aged overweight men.
    Paoli A; Pacelli QF; Moro T; Marcolin G; Neri M; Battaglia G; Sergi G; Bolzetta F; Bianco A
    Lipids Health Dis; 2013 Sep; 12():131. PubMed ID: 24004639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy.
    Puzo J; Alfonso P; Irun P; Gervas J; Pocovi M; Giraldo P
    Atherosclerosis; 2010 Apr; 209(2):515-9. PubMed ID: 19959168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.